Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 228Leukemia, Lymphocytic, Chronic, B-Cell 211Leukemia 201Myelodysplastic Syndromes 184Precursor Cell Lymphoblastic Leukemia-Lymphoma 172Lymphoma 147Lymphoma, Non-Hodgkin 141Multiple Myeloma 130Hodgkin Disease 121Lymphoma, Follicular 110Lymphoma, Mantle-Cell 107Lymphoma, Large B-Cell, Diffuse 95Lymphoma, B-Cell, Marginal Zone 88Myeloproliferative Disorders 86Congenital Abnormalities 84Burkitt Lymphoma 84Leukemia, Myelomonocytic, Chronic 77Leukemia, Myelogenous, Chronic, BCR-ABL Positive 75Leukemia, Myeloid, Chronic-Phase 74Leukemia, Myeloid, Accelerated Phase 72Recurrence 62Melanoma 62Lymphoma, Large-Cell, Immunoblastic 60Anemia, Refractory, with Excess of Blasts 60Primary Myelofibrosis 55Neoplasms, Plasma Cell 55Waldenstrom Macroglobulinemia 54Blast Crisis 54Hematologic Neoplasms 44Lymphoma, T-Cell, Cutaneous 42

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Standard of Care 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Metabolism, Inborn Errors × fludarabine phosphate × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡